Skip to main content

Advertisement

Log in

Progressive necrotic encephalopathy following tacrolimus therapy for liver transplantation

  • Case Report
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Previously described neurologic damage induced by immunosuppressive treatments includes transient or reversible central nervous system involvement. We describe a 57-year-old man who underwent liver transplantation and was started on immunosuppressive therapy with tacrolimus (FK506). Six months later, he started complaining of a progressive motor and sensory impairment of the left side, together with cognitive impairment. Brain MRI showed an enlarging lesion of the white matter with peripheral contrast enhancement. PET study indicated severe hypometabolism in the right hemisphere and spectroscopic MRI showed a peak of choline and relative reduction of other metabolites. Findings of CSF examinations and cultures, serology, and molecular techniques were normal. Tacrolimus treatment was stopped. A cerebral biopsy of the lesion showed a sub acute necrotizing process. In the following months, cognitive status of the patient tended to improve although he remained hemiplegic, while serial MRI confirmed the tendency to the recovery of the lesion that was still present 1 year after. The present observation describes a progressive encephalopathy associated with immune suppression with an unusual feature and permanent brain damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Widjdicks EFM, Wiesnwe RH, Dahlke LJ et al (1994) FK 506-induced neurotoxicity in liver transplantation. Ann Neurol 35:498–501

    Article  Google Scholar 

  2. McDiarmid SV, Busuttil RW, Ascher NL et al (1995) FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation 59:530–536

    CAS  PubMed  Google Scholar 

  3. Won SC, Kwon SY, Han JW, Choi SY, Lyu CJ (2009) Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. J Pediatr Hematol Oncol 31:505–508

    Article  PubMed  Google Scholar 

  4. Schuuring J, Wesseling P, Verrips A (2003) Severe tacrolimus leukoencephalopathy after liver transplantation. AJNR Am J Neuroradiol 24:2085–2088

    PubMed  Google Scholar 

  5. Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500

    Article  CAS  PubMed  Google Scholar 

  6. Singh N, Bonham A, Fukui M (2000) Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 69:467–472

    Article  CAS  PubMed  Google Scholar 

  7. Eng PM, Turnbull BR, Cook SF et al (2006) Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population. Neurology 67:884–886

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

The authors report no conflict of interest, nor do they have anything to display.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanni Savettieri.

Additional information

P. Aridon and P. Ragonese have equally contributed to this paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aridon, P., Ragonese, P., Di Benedetto, N. et al. Progressive necrotic encephalopathy following tacrolimus therapy for liver transplantation. Neurol Sci 30, 527–529 (2009). https://doi.org/10.1007/s10072-009-0149-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-009-0149-0

Keywords

Navigation